Stock Comparison

LYEL vs AAPL

Side-by-side fundamentals, quality, value, and price momentum analysis.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Quick presets:

Metrics Comparison

Best values highlighted in green, worst in red. Scroll horizontally to see all tickers.

MetricLYELLyell Immunopharma, Inc.AAPLApple Inc.
Market Cap$487.12M$3.8T
Current Price$22.93$258.21
P/E Ratio-17.5034.61
Revenue Growth 1Y-53.1%6.4%
Net Margin-5622.9%26.9%
ROE-66.1%171.4%
ROIC-59.2%70.6%
Debt/Equity0.151.34
FCF Yield2.6%
Dividend Yield0.4%
Loading chart...

LYEL vs AAPL: Key Questions Answered

Which stock is growing the fastest: LYEL or AAPL?

Apple Inc. (AAPL) is growing the fastest with 6.4% revenue growth. Lyell Immunopharma, Inc. has the slowest growth at -53.1%. Higher growth often justifies higher valuations.

Which has the best profit margins: LYEL or AAPL?

Apple Inc. (AAPL) has the strongest profitability with a 26.9% net margin. Lyell Immunopharma, Inc. has the lowest at -5622.9%. Higher margins indicate pricing power and efficiency.

Which is the largest company: LYEL or AAPL?

Apple Inc. (AAPL) is the largest company with a market cap of $3.80T. Lyell Immunopharma, Inc. is the smallest at $0.5B. Larger companies tend to be more stable but may have less growth potential.

Which stock has the best return on equity: LYEL or AAPL?

Apple Inc. (AAPL) generates the best returns on shareholder equity with an ROE of 1.7%. Lyell Immunopharma, Inc. has the lowest at -66.1%. Higher ROE indicates efficient use of capital.